понедельник, 19 декабря 2016 г.

Exclusive: Biogen to name top executive Vounatsos as CEO - sources

Exclusive: Biogen to name top executive Vounatsos as CEO - sources


Biogen Inc, the U.S. drug maker focused on neurological, autoimmune and rare diseases, said on Monday it had appointed its chief commercial officer, Michel Vounatsos, as chief executive officer. The move comes as the Cambridge, Massachusetts-based company is seeking to develop its promising spinal muscular atrophy and Alzheimer's disease drugs.



from Biotech News